IngenoVax
Research - Boulder, Colorado, United States
IngenoVax Employees
IngenoVax Details
Guided by advances in genomics and proteomics, IngenoVax has developed a novel, fully-synthetic cancer vaccine platform ("Microbial Mimetics") for the immunotherapy of a wide range of solid tumor types, further rendering them susceptible to immune checkpoint inhibitor therapy. With proof of concept studies completed and IP issued, we are performing IND-enablement studies for our lead candidate.
Website:
http://www.ingenovax.com
Employees:
0
HQ:
Location:
Boulder, Colorado, United States
Revenue: